Background
In July 2005, at the G8 summit in Gleneagles, G8
leaders made a commitment to:
"…working with WHO, UNAIDS and other
international bodies to develop and implement a package of HIV
prevention, treatment and care, with the aim of as close as possible
to universal access to treatment for all those who need it by
2010."[1]
This commitment was reaffirmed at the UN Millennium
Review Summit, in New York, in September 2005. On 19 October,
the Committee announced that it would inquire into HIV/AIDS and
the provision of anti-retrovirals (ARVs), inviting organisations
and individuals with relevant experience and expertise to submit
written evidence.
We received written memoranda from 17 individuals
and organisations, and took evidence from two sets of witnesses
at Westminster. We would like to thank the following individuals
who gave oral evidence: Dr Mandeep Dhaliwal, Head, Care &
Impact Mitigation, International HIV/AIDS Alliance and the Stop
AIDS Campaign; Dr Tom Ellman, Medical Adviser, Médecins
Sans Frontières (UK); Ms Sandra Black, Senior Policy Advisor,
HIV/AIDS Department, World Health Organisation (WHO); Mr Ben Plumley,
Director, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Executive Office; Mr Hans-Martin Boehmer, Head of Human Development
Group, Policy Division; Ms Robin Gorna, Senior AIDS adviser and
team leader, Policy Division; and, Mr Daniel Graymore, Private
Sector Adviser, Global AIDS policy team, Policy Division, Department
for International Development (DFID).
1 G8 post-summit communiqué, Gleneagles, Scotland,
July 2005 Back
|
